CHRU de Brest
Brest, 29609, France
NCT Number: NCT04097847
osteoradionecrosis (ORN) affects up to 30% of irradiated patients and can occur up to several decades after stopping treatment. Differents therapeutics exist but there is no consensus concerning the management of the maxillary ORN. The understanding of new pathological mechanisms opens the way to new therapeutic perspectives.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the aim of this retrospective study is to analyze from patient records the impact of the PENTOCLO protocol on maxillofacial osteoradionecrosis at Brest Hospital University, France.
Other names: Pentoclo
Time frame: 2 years
Retrospective study based on recovering patient data from medical records
University Hospital, Brest
Other
Osteoradionecrosis and PENTOCLO Protocol: Retrospective Study.
Acronym: OPEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03905005
Bone Diseases, Bone Neoplasms
Swansea, United Kingdom
View Trial DetailsNCT06055257
Head and Neck Neoplasms, Neoplasms
Toronto, Ontario, Canada
View Trial Details